Gallus Biopharmaceuticals to Retain/Add 320 Jobs in Missouri
05/22/2011
Recently Gallus purchased the former 15-acre, 200,000-square-foot Centocor Biologics facility in Berkeley. The company plans to make an initial capital investment of $20 million to expand the facility, hire about 160 Centocor employees; and create about 160 new jobs over the next five years. The average salary is expected to be $88,500.
Gallus Biopharmaceuticals is a contract manufacturer of pharmaceuticals produced from cell cultures. It plans on expanding the commercially certified, FDA-approved facilities at the former Centocor plant by building a clinical services suite, expanding the existing development lab and fitting out a commercial suite.
The state of Missouri awarded Gallus a $14.6 million economic incentive package, redeemable over the next 10 years.
Project Announcements
Brightline West-Siemens Mobility Plans Horseheads, New York, Production Operations
09/11/2024
TCI Tank Logistics Expands Port of New Orleans, Louisiana, Transloading Operations
09/11/2024
Unified Resources in Display Plans Hardeeville, South Carolina, Manufacturing Operations
09/11/2024
Raymond Corporation-Toyota Material Handling Expands Kirkwood, New York, Operations
09/11/2024
Builders Supply Co. Expands Fort Payne, Alabama, Manufacturing Operations
09/11/2024
Kentucky Aluminum Processors Plans Russellville, Kentucky, Operations
09/10/2024
Most Read
-
Semiconductors’ Fragile Relationship With Water May Be Tested
Q3 2024
-
What the Latest EPA PFAS Rule Means for Site Due Diligence
Q3 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
19th Annual Area Development Gold and Silver Shovel Awards
Q2 2024
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023